PHARMENA SA at FIBO 2026: Advancing Longevity through 1-MNA

At the FIBO 2026 exhibition, PHARMENA SA established itself as a dynamic player in the biotechnology sector. The Poland-based company presented its latest developments in the field of dietary supplements, focusing on the innovative use of the 1-MNA molecule to optimize NAD+ levels. Presenting at stand 5.2B50, the company showcased how scientific discoveries can be translated into practical nutritional solutions designed to support cellular health and promote longevity.

Scientific Foundation for Longevity

PHARMENA SA positioned itself as a pioneer for products based on the patented active ingredient 1-MNA. This molecule is a substance that occurs naturally in the human body, arising from the metabolism of niacin and playing a central role in the synthesis of coenzymes. The solutions showcased aimed to support cellular health and promote the longevity process (lifespan). Through clinically tested ingredients, the formulations were designed to support cell division processes and proper DNA synthesis.

The product range presented at stand 5.2B50 demonstrated the diverse applications of the Endotelio brand:

• Endotelio Brain: This formulation was specifically developed to support cognitive functions and concentration while providing protection against oxidative stress.
• Endotelio Wellbeing: This solution focused on the reduction of tiredness and fatigue as well as the maintenance of normal psychological functions. It contains highly standardized Ashwagandha KSM-66® extract.
• Endotelio Cellular Energy: This variant was designed for individuals with an intensive lifestyle to support energy metabolism and the proper functioning of muscles.

Relevance for Fitness and Health

For the professionals and trainers at FIBO, the specific target-group approaches were of particular interest. Because 1-MNA supports endurance and cellular protection, the products offer a direct resource for physically active people. The combination of the 1-MNA molecule with additional ingredients, such as trans-resveratrol (Veri-te™), makes these solutions a targeted supplement to modern nutritional strategies.

By introducing the Endotelio series, PHARMENA SA demonstrated how scientific discoveries can be translated into practical dietary supplements. The focus on optimizing NAD+ levels underscores the company's ambition to pursue innovative paths for healthy aging and increased vitality. The presentation at stand 5.2B50 concluded as a scientifically grounded retrospective of a successful exhibition presence.

Further information regarding the portfolio is available at https://Endotelio.eu.

Further information about the company and its showcased topics is available at https://endotelio.eu.